We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Biotage AB (BIOT) NPV

Sell:179.00 SEK Buy:179.40 SEK Change: 0.40 SEK (0.22%)
Market closed |  Prices as at close on 17 May 2024 | Switch to live prices |
Sell:179.00 SEK
Buy:179.40 SEK
Change: 0.40 SEK (0.22%)
Market closed |  Prices as at close on 17 May 2024 | Switch to live prices |
Sell:179.00 SEK
Buy:179.40 SEK
Change: 0.40 SEK (0.22%)
Market closed |  Prices as at close on 17 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Biotage AB is a Sweden-based company that develops and sells systems, consumables and services in the field of life sciences. Its customers include pharmaceutical and biotechnology companies, companies within the food industry and academic institutions. The Company offers systems and services within three areas: analytical chemistry, organic chemistry and industrial resins. Biotage’s offering within analytical chemistry consists of consumables with related applications to extract selected substances from various types of samples. The Company’s offering within organic chemistry includes products for pharmaceutical development based on both small molecules and peptides and its offering within industrial resins is composed of polymer-based resins and research services that lead to the development and manufacture of polymer-based materials. As of December 31, 2013, the Company operated 12 wholly owned subsidiaries worldwide.

Contact details

Vimpelgatan 5
753 18
+46 (18) 565900

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
14.36 billion SEK
Shares in issue:
80.01 million
Life Sciences Tools & Services
Stockholm Stock Exchange
Swedish Krona

Key personnel

  • Torben Joergensen
    Interim President and Chief Executive Officer, Director
  • Andrew Kellett
    Chief Financial Officer
  • Scott Carr
    President, Americas
  • Andreas Juhlin
    President International
  • Petra Duprez
    Chief Human Resource Officer and Sustainability Officer
  • Raffaella Bombarda
    Executive Vice President - Global Marketing
  • Lisa Egelrud
    Executive Vice President - Quality Assurance Regulatory Affairs
  • Olof Nord
    Executive Vice President - Business Development
  • Magnus Nordstedt
    Executive Vice President - IT and Digitalization
  • Anders Wikstroem
    Executive Vice President - Operations

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.